The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort
Abstract
Usage of cancer cell lines has repeatedly generated conflicting results provoked by differences among subclones or contamination with mycoplasm or other immortal mammalian cells. To overcome these limitations, we decided within the EuroBoNeT consortium to characterize a common set of cell lines including osteosarcomas (OS), Ewing sarcomas (ES), and chondrosarcomas (CS). DNA fingerprinting was used to guarantee the identity of all of the cell lines and to distinguish subclones of osteosarcoma cell line HOS. Screening for homozygous loss of 38 tumor suppressor genes by MLPA revealed deletion of CDKN2A as the most common event (15/36), strictly associated with absence of the CDKN2A (p16) protein. Ten cell lines showed missense mutations of the TP53 gene while another set of nine cell lines showed mutations resulting in truncation of the TP53 protein. Cells harboring missense mutations expressed high levels of nuclear TP53, while cell lines with nonsense mutations showed weak/absent staining for TP53. TP53wt cell lines usually expressed the protein in 2–10% of the cells. However, seven TP53wt osteosarcomas were negative for both mRNA and protein expression. Our analyses shed light on the correlation between immunohistochemical and genetic data for CDKN2A and TP53, and confirm the importance of these signaling pathways. The characterization of a substantial number of cell lines represents an important step to supply research groups with proven models for further advanced studies on tumor biology and may help to make results from different laboratories more comparable. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“Finally, p53 protein is assumed to be regulated to a large extent by posttranscriptional mechanisms (Vogelstein et al., 2000) and almost no data are available addressing the transcriptional control of TP53 (reviewed in Hall and McCluggage, 2006).”
BackgroundGarraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Cross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329
Cited by
Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508
Self-citationLuca, A. C., Mersch, S., Deenen, R., Schmidt, S., Messner, I., Schäfer, K.-L., Baldus, S. E., Huckenbeck, W., Piekorz, R. P., Knoefel, W. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059689 · Cited by 341
Self-citationModulation of the Osteosarcoma Expression Phenotype by MicroRNAs
Namløs, H. M., Meza-Zepeda, L. A., Barøy, T., Østensen, I. H. G., Kresse, S. H., Kuijjer, M. L., Serra, M., Bürger, H., Cleton-Jansen, A.-M., & Myklebost, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048086 · Cited by 264
Self-citationKailayangiri, S., Altvater, B., Spurny, C., Jamitzky, S., Schelhaas, S., Jacobs, A. H., Wiek, C., Roellecke, K., Hanenberg, H., Hartmann, W., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1250050 · Cited by 104
Metadata
- Authors
- Ottaviano, L., Schaefer, K., Gajewski, M., Huckenbeck, W., Baldus, S., Rogel, U., Mackintosh, C., de Alava, E., Myklebost, O., Kresse, S. H., Meza‐Zepeda, L. A., Serra, M., Cleton‐Jansen, A., Hogendoorn, P. C. W., Buerger, H., Aigner, T., Gabbert, H. E., & Poremba, C.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2009-09-29
- Volume
- 49
- Issue
- 1
- Pages
- 40-51
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2141419938
- Cited by
- 172
- References
- 3
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort. https://app.cochat.ai/papers/10.1002/gcc.20717
- The paper
- Ottaviano, L., Schaefer, K., Gajewski, M., Huckenbeck, W., Baldus, S., Rogel, U., Mackintosh, C., de Alava, E., Myklebost, O., Kresse, S. H., Meza‐Zepeda, L. A., Serra, M., Cleton‐Jansen, A., Hogendoorn, P. C. W., Buerger, H., Aigner, T., Gabbert, H. E., & Poremba, C. (2010). Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.20717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.